Xuanbo Zhang

110016, PR China
Shenyang, Puerto Rico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Redox modulation of antitumor immunity via nanomedicine.

Redox modulation of antitumor immunity via nanomedicine.

Journal: Advanced drug delivery reviews
Published: December 27, 2025

Leveraging Cisplatin-Derived Prodrugs as Helper Lipids in LNPs to Boost the Efficacy of Cancer Chemoimmunotherapy.

Leveraging Cisplatin-Derived Prodrugs as Helper Lipids in LNPs to Boost the Efficacy of Cancer Chemoimmunotherapy.

Journal: ACS nano
Published: December 22, 2025

Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic phototherapy.

Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic phototherapy.

Journal: Bioactive materials
Published: October 28, 2020

Emerging nanotherapeutics for antithrombotic treatment.

Emerging nanotherapeutics for antithrombotic treatment.

Journal: Biomaterials
Published: January 01, 2020

An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition.

An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition.

Journal: Biomaterials
Published: December 23, 2019

Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.

Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.

Journal: Acta biomaterialia
Published: January 25, 2019

Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy.

Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 19, 2018

Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.

Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.

Journal: Nano letters
Published: May 05, 2018
Showing 1-8 of 8

Last Updated: 09/26/2026